Where is Daiichi Sankyo headquarters?
Chuo City, Tokyo, Japan
Is Daiichi Sankyo a big company?
Daiichi Sankyo Company, Limited (Japanese: 第一三共株式会社, Hepburn: Daiichi Sankyō Kabushiki-gaisha) is a global pharmaceutical company and the second-largest pharmaceutical company in Japan. It achieved JPY 981.8 billion in revenue in 2019.
What does Daiichi Sankyo do?
The Daiichi Sankyo group is actively engaged in various measures and initiatives such as, but not limited to, contributing to vaccination and drug research and development, ensuring a continuous supply of Daiichi Sankyo group company products, and providing disaster relief support.
What is Daiichi?
Dai-ichi (第一) is a compound modifier phrase of Japanese origin, meaning number one, or first. In kanji, “dai” (“number”) is 第 and “ichi” (“one”) is 一. Number one functions in the same way. The phrase is also written without the hyphen, as daiichi.
When was Daiichi Sankyo founded?
September 28, 2005, Tokyo, Japan
What drugs does Daiichi Sankyo make?
Is Astellas owned by Pfizer?
In October 2009, Medivation, Inc., which is now part of Pfizer (NYSE:PFE), and Astellas (TSE: 4503) entered into a global agreement to jointly develop and commercialize enzalutamide.
Is astellas a Japanese company?
Astellas Pharma Inc. (アステラス製薬株式会社, Asuterasu Seiyaku Kabushiki-gaisha) is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd.
Who manufactures olmesartan medoxomil?
Olmesartan medoxomil is an orally active angiotensin receptor antagonist that has been developed by Daiichi Sankyo Company.